⌘K

Login Start Free

Home/Filings/4/0001104659-22-103166

4//SEC Filing

Shemesh Shay 4

Accession 0001104659-22-103166

CIK 0001875558other

View on SEC.gov Company Profile

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 8:45 AM ET

Size

4.6 KB

Accession

0001104659-22-103166

Insider Transaction Report

Form 4

Period: 2022-09-23

Nuvectis Pharma, Inc.NVCT

Chief Dev. & Ops. Officer

Transactions

Purchase
Common Stock
2022-09-23$7.87/sh+220$1,731→ 1,245,065 total

Footnotes (1)

[F1]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.

Documents

1 file

4
tm2226689-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Nuvectis Pharma, Inc.

CIK 0001875558

Entity typeother

Related Parties

1

filerCIK 0001896056

Filing Metadata

Form type: 4
Filed: Sep 26, 8:00 PM ET
Accepted: Sep 27, 8:45 AM ET
Size: 4.6 KB

View on SEC.gov